Keyphrases
Vaccination
100%
Immune Response
100%
R848
100%
Route of Administration
50%
Antigen-presenting Cells
50%
Immunization
50%
Intranasal
50%
Intradermal Immunization
50%
Tumor-draining Lymph Nodes
33%
Immunization Programs
33%
Intranasal Immunization
33%
Interleukin-10
16%
IL-10 Production
16%
Dendritic Cells
16%
Two-route Scenario
16%
Rational Development
16%
Relative Abundance
16%
T Cells
16%
T Cell Activation
16%
T Cell Response
16%
Vaccine Response
16%
Adaptive Response
16%
Adaptive Immune Response
16%
Interleukin-17 (IL-17)
16%
Mucosal Immunity
16%
Memory Response
16%
Macrophage Cells
16%
Vaccine Adjuvant
16%
CD103
16%
Neutrophil Cells
16%
Immunological Outcomes
16%
Stimulatory Effect
16%
Cell Recruitment
16%
Innate Cells
16%
Toll-like Receptor 7 (TLR7)
16%
Cytokine Profile
16%
Immune Stimulation
16%
DC Subsets
16%
Intramuscular Route
16%
Dose Sparing
16%
Intradermal Route
16%
Traditional Vaccines
16%
Needle-free Immunization
16%
Model Antigen
16%
CD11b+
16%
Immunology and Microbiology
Immune Response
100%
Vaccination Policy
100%
Resiquimod
100%
Vaccine Efficacy
50%
Antigen-Presenting Cell
50%
T Cell
33%
Lymph Node
33%
T Cell Activation
16%
Dendritic Cell
16%
Adaptive Immune System
16%
Interleukin 17
16%
Macrophage
16%
Neutrophil Granulocyte
16%
Agonist
16%
TLR7
16%
Mucosal Immunity
16%
Cytokine
16%
Pharmacology, Toxicology and Pharmaceutical Science
Resiquimod
100%
Vaccination Policy
100%
Route of Administration
50%
Intramuscular Route
16%
Cytokine
16%
Toll Like Receptor 7
16%
Interleukin 17
16%